Hiroshige Itakura
About
In The Last Decade
Hiroshige Itakura
165 papers receiving 9.0k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Surgery 3.4k
- Nutrition and Dietetics 2.7k
- Endocrinology, Diabetes and Metabolism 2.4k
- Molecular Biology 1.7k
- Cardiology and Cardiovascular Medicine 1.5k
Countries citing papers authored by Hiroshige Itakura
This map shows the geographic impact of Hiroshige Itakura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshige Itakura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshige Itakura more than expected).
Fields of papers citing papers by Hiroshige Itakura
This network shows the impact of papers produced by Hiroshige Itakura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshige Itakura. The network helps show where Hiroshige Itakura may publish in the future.
Co-authorship network of co-authors of Hiroshige Itakura
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshige Itakura. A scholar is included among the top collaborators of Hiroshige Itakura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshige Itakura. Hiroshige Itakura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Practice Guideline for Zinc Deficiency | 21 |
| 2 | 181 | |
| 3 | 10 | |
| 4 | Incremental Effects of Eicosapentaenoic Acid on Cardiovascular Events in Statin-Treated Patients With Coronary Artery Disease Secondary Prevention Analysis From JELIS | 30 |
| 5 | 162 | |
| 6 | 8 | |
| 7 | Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial breakdown → | 686 |
| 8 | 37 | |
| 9 | 16 | |
| 10 | 51321例の日本人高コレステロール血症患者を対象とした最小副作用での6年間の低容量シンバスタチン療法における血清コレステロールの持続的低下 大規模全国コホート試験J-LIT試験の意義 | 39 |
| 11 | 55 | |
| 12 | 34 | |
| 13 | 26 | |
| 14 | 29 | |
| 15 | 50 | |
| 16 | 126 | |
| 17 | 6 | |
| 18 | 3 | |
| 19 | 2 | |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.